Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

13 trials with published results (24%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.4%

4 terminated out of 54 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

19%

10 trials in Phase 3/4

Results Transparency

36%

13 of 36 completed with results

Key Signals

13 with results90% success

Data Visualizations

Phase Distribution

42Total
Not Applicable (20)
P 1 (6)
P 2 (6)
P 3 (5)
P 4 (5)

Trial Status

Completed36
Unknown8
Terminated4
Recruiting3
Active Not Recruiting2
Enrolling By Invitation1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 36 completed trials

Clinical Trials (54)

Showing 20 of 20 trials
NCT05557058Not ApplicableActive Not RecruitingPrimary

GORE Glaucoma Drainage Implant Clinical Study Dominican Republic

NCT05264818RecruitingPrimary

Assessment of Endothelial Glycocalyx in Patients With Primary Open-angle Glaucoma

NCT03673644Active Not RecruitingPrimary

Impact of Glaucoma and Visual Field Loss on Life Space

NCT06321562Phase 1TerminatedPrimary

Safety and Tolerability of a Timolol Releasing Intraocular Implant in Subjects With Primary Open-angle Glaucoma

NCT03921931Not ApplicableRecruiting

Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study

NCT03651336Not ApplicableCompletedPrimary

Long-term Safety and Performance of the ARGOS-IO Intraocular Pressure Sensor System in Subjects With Primary Open Angle Glaucoma (POAG)

NCT03193333Phase 3TerminatedPrimary

PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)

NCT05432245Not ApplicableEnrolling By InvitationPrimary

MINIject Implantation Combined With Cataract Surgery in Patients With POAG and Cataract

NCT04519814Not ApplicableCompletedPrimary

Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT)

NCT05253534Not ApplicableCompletedPrimary

GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma

NCT06692205RecruitingPrimary

Effects of Primary Open-angle Glaucoma on Visual-motor Coordination

NCT05247762Not ApplicableCompletedPrimary

Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma

NCT04333433CompletedPrimary

PRESERFLO® MicroShunt Extension Study

NCT03931564Not ApplicableUnknownPrimary

SIGHT Study: Cost-effectiveness of InnFocus Microshunt Implantation vs. Trabeculectomy.

NCT03235232Phase 3Completed

BREMEN Eye Drops Versus Combigan for Open-angle Glaucoma or Intraocular Hypertension

NCT03273907Not ApplicableTerminatedPrimary

Post Approval Study of the CyPass System

NCT02617459Phase 3CompletedPrimary

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

NCT02327312Not ApplicableTerminatedPrimary

Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty

NCT03480711Not ApplicableCompletedPrimary

Modified Trabeculectomy With an ESST Versus Conventional SST for Management of Primary Open Angle Glaucoma

NCT01461278Not ApplicableCompletedPrimary

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery

Scroll to load more

Research Network

Activity Timeline